|
| related topics |
| {product, market, service} |
| {product, candidate, development} |
| {acquisition, growth, future} |
| {system, service, information} |
| {operation, international, foreign} |
| {property, intellectual, protect} |
| {regulation, government, change} |
| {stock, price, operating} |
| {customer, product, revenue} |
|
|
If we do not continue to enhance our software, we may not be able to meet the evolving needs of our customers.
Our quarterly results fluctuate significantly.
Our business strategies are unproven and we are in an early stage of development.
We may lose revenue if we experience delays in clinical trials or if we lose contracts.
We may lose future revenue if our major customers decrease their research and development expenditures, or if we lose any of our major customers.
Changes in government regulations relating to the health care industry could have a material adverse effect on the demand for our services.
We may not be able to capture or establish the market presence necessary to compete in the EDC market.
We may be subject to liability for potential breaches of contracts or a loss of or unauthorized release of clinical trial data.
Fluctuations in foreign currency exchange rates may adversely affect our results of operations and financial condition.
Our competitive position and business may be adversely affected if we are unable to protect our intellectual property rights or if we infringe upon the intellectual property rights of others.
We may not be able to successfully integrate and profitably manage our acquired business and our new software offering without substantial costs, delays or other problems. Acquisitions also may involve a number of special risks some or all of which could have a material adverse effect on our business, results of operations and financial condition. Examples of special risks relating to acquisitions include:
Full 10-K form ▸
|
|
| related documents |
| 886530--3/13/2006--DATATRAK_INTERNATIONAL_INC |
| 886530--3/16/2009--DATATRAK_INTERNATIONAL_INC |
| 886530--3/16/2007--DATATRAK_INTERNATIONAL_INC |
| 724004--6/29/2009--MESA_LABORATORIES_INC_/CO |
| 724004--6/30/2008--MESA_LABORATORIES_INC_/CO |
| 724004--6/29/2010--MESA_LABORATORIES_INC_/CO |
| 64978--3/13/2006--MERCK_&_CO_INC |
| 23259--3/31/2006--CT_COMMUNICATIONS_INC_/NC |
| 28626--9/13/2007--LIFECORE_BIOMEDICAL_INC |
| 874734--3/12/2008--OSTEOTECH_INC |
| 752294--3/26/2010--ELECTRONIC_SYSTEMS_TECHNOLOGY_INC |
| 855683--3/17/2009--MILESTONE_SCIENTIFIC_INC/NJ |
| 1114200--2/28/2007--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC |
| 1054579--4/21/2008--HASTINGS_ENTERTAINMENT_INC |
| 1129096--10/29/2008--INFITECH_VENTURES_INC |
| 911149--4/2/2007--MICRO_COMPONENT_TECHNOLOGY_INC |
| 911149--3/31/2006--MICRO_COMPONENT_TECHNOLOGY_INC |
| 1114200--3/1/2010--AMERICAN_MEDICAL_SYSTEMS_HOLDINGS_INC |
| 28626--9/13/2006--LIFECORE_BIOMEDICAL_INC |
| 1026650--3/7/2008--ERESEARCHTECHNOLOGY_INC_/DE/ |
| 911649--3/31/2006--STRATEGIC_DIAGNOSTICS_INC/DE/ |
| 744825--3/31/2009--AMERICAN_SHARED_HOSPITAL_SERVICES |
| 59527--2/25/2008--LINCOLN_ELECTRIC_HOLDINGS_INC |
| 832101--3/1/2010--IDEX_CORP_/DE/ |
| 64978--2/28/2007--MERCK_&_CO_INC |
| 732712--2/26/2010--VERIZON_COMMUNICATIONS_INC |
| 899866--2/23/2009--ALEXION_PHARMACEUTICALS_INC |
| 799426--4/15/2009--NEW_WORLD_BRANDS_INC |
| 1101026--4/14/2010--HEALTH_ENHANCEMENT_PRODUCTS_INC |
| 1001288--2/27/2009--LEXMARK_INTERNATIONAL_INC_/KY/ |
|